Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-yang Wang

Showing results (181-190 of 248) with videos related to

Pageof 25
Sort By:
Cancer Science|September 17, 2022
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinomaChun Yang, Xiao-Wen Cui, Zhi-Wen Ding, et al.
Science Translational Medicine|September 24, 2020
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinomaTian-Yi Jiang, Yu-Fei Pan, Zheng-Hua Wan, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
Proteomics|March 11, 2005
Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markersChen Li, Ye-Xiong Tan, Hu Zhou, et al.
Chinese Medical Journal|April 12, 2016
Clinical Study on 136 Children with Sudden Sensorineural Hearing LossFeng-Jiao Li, Da-Yong Wang, Hong-Yang Wang, et al.
Genome Medicine|August 13, 2024
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinomaSi-Yu Jing, Dan Liu, Na Feng, et al.
Clinical and Translational Medicine|May 1, 2024
Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trialTian-Mei Zeng, Tian-Yi Jiang, Guang Yang, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysJing Fu, Yao Chen, Jie Cao, et al.
Hepatology (Baltimore, Md.)|September 7, 2004
Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1He-Xin Yan, Hong-Yang Wang, Rui Zhang, et al.
Gastroenterology|January 20, 2009
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell featuresTaro Yamashita, Junfang Ji, Anuradha Budhu, et al.
Pageof 25

Showing results (181-190 of 248) with videos related to

Sort By:
Pageof 25
Cancer Science|September 17, 2022
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinomaChun Yang, Xiao-Wen Cui, Zhi-Wen Ding, et al.
Science Translational Medicine|September 24, 2020
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinomaTian-Yi Jiang, Yu-Fei Pan, Zheng-Hua Wan, et al.
Molecular & Cellular Proteomics : MCP|November 1, 2003
From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasisShi-Jian Ding, Yan Li, Ye-Xiong Tan, et al.
Proteomics|March 11, 2005
Proteomic analysis of hepatitis B virus-associated hepatocellular carcinoma: Identification of potential tumor markersChen Li, Ye-Xiong Tan, Hu Zhou, et al.
Chinese Medical Journal|April 12, 2016
Clinical Study on 136 Children with Sudden Sensorineural Hearing LossFeng-Jiao Li, Da-Yong Wang, Hong-Yang Wang, et al.
Genome Medicine|August 13, 2024
Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinomaSi-Yu Jing, Dan Liu, Na Feng, et al.
Clinical and Translational Medicine|May 1, 2024
Bortezomib in previously treated phosphatase and tension homology-deficient patients with advanced intrahepatic cholangiocarcinoma: An open-label, prospective and single-centre phase II trialTian-Mei Zeng, Tian-Yi Jiang, Guang Yang, et al.
Hepatology (Baltimore, Md.)|January 22, 2011
p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxia-inducible factor-1α pathwaysJing Fu, Yao Chen, Jie Cao, et al.
Hepatology (Baltimore, Md.)|September 7, 2004
Negative regulation of hepatocellular carcinoma cell growth by signal regulatory protein alpha1He-Xin Yan, Hong-Yang Wang, Rui Zhang, et al.
Gastroenterology|January 20, 2009
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell featuresTaro Yamashita, Junfang Ji, Anuradha Budhu, et al.
Pageof 25